ADAPLANE 0.1%

ADAPLANE 0.1% was reported 5297 times

ADAPLANE 0.1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPASTIC DIPLEGIA 1 0.0833
1 BILIRUBIN CONJUGATED 2 0.0625
2 NITRITE URINE 1 0.0370
3 OSTEOMA CUTIS 1 0.0294
4 PURGING 3 0.0288
5 SCAR INFLAMMATION 1 0.0286
6 APPLICATION SITE PHOTOSENSITIVITY REACTION 1 0.0270
7 BENIGN SOFT TISSUE NEOPLASM 1 0.0263
8 KIDNEY MALROTATION 1 0.0244
9 APPLICATION SITE DRYNESS 80 0.0235
10 CHEMICAL BURN 26 0.0225
11 BLOOD ARSENIC INCREASED 1 0.0185
12 GAMMA-GLUTAMYLTRANSFERASE 2 0.0183
13 AMYLASE DECREASED 2 0.0180
14 ABSCESS OF EYELID 1 0.0179
15 STICKY SKIN 7 0.0175
16 EXPOSURE VIA MUCOSA 1 0.0167
17 ACNE FULMINANS 3 0.0153
18 UNADJUSTED DOSE ADMINISTERED 1 0.0147
19 KLEPTOMANIA 1 0.0137
20 PRODUCT INTOLERANCE 3 0.0135
21 DIAPHRAGMATIC INJURY 1 0.0135
22 BLADDER TRABECULATION 1 0.0123
23 VERTEBRAL WEDGING 1 0.0111
24 POLYMORPHIC LIGHT ERUPTION 1 0.0108
25 SKIN IRRITATION 490 0.0107
26 MYELOMALACIA 1 0.0095
27 SENSITIVE SKIN 70 0.0095
28 HYPERCORTICOIDISM 1 0.0094
29 HYPERTROPHIC SCAR 1 0.0092
30 TRAUMATIC SHOCK 1 0.0087
31 FIXED DRUG ERUPTION 1 0.0082
32 CHEMICAL BURN OF SKIN 20 0.0079
33 MAGNETIC RESONANCE IMAGING 1 0.0078
34 SEBORRHOEA 28 0.0076
35 SPINAL FUSION ACQUIRED 2 0.0073
36 PINEAL GLAND CYST 1 0.0071
37 ADMINISTRATION SITE IRRITATION 1 0.0071
38 HLA-B*27 POSITIVE 1 0.0071
39 BURNS FIRST DEGREE 2 0.0070
40 STOMA PROLAPSE 1 0.0070
41 SKIN BURNING SENSATION 501 0.0070
42 SLOW RESPONSE TO STIMULI 9 0.0069
43 SKIN DISCOMFORT 17 0.0063
44 ACNE 472 0.0062
45 DRY SKIN 817 0.0061
46 ACNE PUSTULAR 5 0.0061
47 RADICULITIS 1 0.0060
48 APPLICATION SITE EXFOLIATION 24 0.0058
49 TRI-IODOTHYRONINE FREE INCREASED 1 0.0058
50 SWELLING OF NOSE 1 0.0058
51 ACNE CYSTIC 17 0.0056
52 INTERCOSTAL NEURALGIA 1 0.0056
53 TINEA VERSICOLOUR 2 0.0056
54 MILIA 2 0.0055
55 BLOOD ZINC DECREASED 1 0.0055
56 POROKERATOSIS 1 0.0054
57 TANGENTIALITY 1 0.0052
58 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
59 PRODUCT ADVERTISING ISSUE 1 0.0047
60 JAW CYST 1 0.0046
61 THERAPY CESSATION 227 0.0044
62 FACIAL PAIN 39 0.0044
63 PERIORBITAL INFLAMMATION 1 0.0043
64 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
65 TRAUMATIC LIVER INJURY 1 0.0043
66 SPLENIC INJURY 1 0.0042
67 SKIN TEXTURE ABNORMAL 4 0.0042
68 EYELID RASH 4 0.0041
69 APPLICATION SITE ACNE 2 0.0041
70 TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME 1 0.0040
71 SKIN TIGHTNESS 19 0.0040
72 KERATOSIS PILARIS 1 0.0040
73 OESOPHAGEAL OPERATION 1 0.0039
74 MONONUCLEOSIS SYNDROME 1 0.0039
75 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
76 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
77 ORTHOSIS USER 1 0.0036
78 NAIL DYSTROPHY 2 0.0036
79 ENTEROBACTER INFECTION 6 0.0036
80 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
81 PAIN OF SKIN 91 0.0034
82 SKIN EXFOLIATION 282 0.0033
83 SKIN INJURY 11 0.0033
84 EUTHANASIA 1 0.0032
85 BLOOD PRESSURE MEASUREMENT 2 0.0031
86 SKIN EROSION 10 0.0031
87 ANOREXIA NERVOSA 1 0.0031
88 WRONG STRENGTH 1 0.0030
89 PERIORBITAL IRRITATION 1 0.0029
90 HYPERALDOSTERONISM 1 0.0029
91 RADICULAR PAIN 1 0.0029
92 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
93 MYOFASCIAL PAIN SYNDROME 2 0.0028
94 EYE SYMPTOM 1 0.0028
95 HEART VALVE STENOSIS 1 0.0028
96 MENISCUS OPERATION 1 0.0028
97 PNEUMOMEDIASTINUM 5 0.0028
98 NASAL SEPTAL OPERATION 1 0.0028
99 GLOBULINS INCREASED 1 0.0027
100 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
101 APPLICATION SITE BURN 13 0.0026
102 HYPOMETABOLISM 1 0.0026
103 BONE MARROW INFILTRATION 1 0.0026
104 PREGNANCY TEST POSITIVE 1 0.0025
105 BLOOD FIBRINOGEN INCREASED 2 0.0025
106 EYELID EXFOLIATION 2 0.0025
107 CHRONIC HEPATITIS C 1 0.0025
108 SCAR 43 0.0025
109 TRICUSPID VALVE DISEASE 1 0.0025
110 DEPENDENCE ON RESPIRATOR 1 0.0025
111 MIXED CONNECTIVE TISSUE DISEASE 1 0.0024
112 PHOTODERMATOSIS 1 0.0024
113 PIGMENTATION DISORDER 14 0.0023
114 JUGULAR VEIN THROMBOSIS 4 0.0022
115 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
116 CIRRHOSIS ALCOHOLIC 1 0.0022
117 APPLICATION SITE INFLAMMATION 3 0.0022
118 CRANIAL NERVE PARALYSIS 1 0.0021
119 SKIN REACTION 29 0.0021
120 DARK CIRCLES UNDER EYES 3 0.0020
121 ROOT CANAL INFECTION 1 0.0020
122 LENTIGO 1 0.0020
123 ABORTION THREATENED 1 0.0020
124 MICROGNATHIA 1 0.0020
125 ERYTHEMA 410 0.0020
126 SKIN HYPERPIGMENTATION 17 0.0020
127 RIGHT ATRIAL DILATATION 1 0.0020
128 MULTIPLE-DRUG RESISTANCE 6 0.0019
129 ABDOMINAL INJURY 1 0.0019
130 BONE DEMINERALISATION 2 0.0019
131 SOMATIC SYMPTOM DISORDER 2 0.0019
132 DRUG INEFFECTIVE 2440 0.0018
133 OESOPHAGEAL ULCER 7 0.0018
134 LIFE EXPECTANCY SHORTENED 1 0.0018
135 CARBON DIOXIDE DECREASED 2 0.0017
136 IRREGULAR BREATHING 1 0.0017
137 PUSTULE 4 0.0017
138 DYSMETRIA 1 0.0017
139 OSTEOMYELITIS CHRONIC 1 0.0016
140 APPLICATION SITE IRRITATION 20 0.0016
141 EYELID IRRITATION 4 0.0016
142 PERIORBITAL SWELLING 9 0.0016
143 STOMA SITE HYPERGRANULATION 1 0.0016
144 GASTRIC NEOPLASM 1 0.0016
145 GLIOMA 1 0.0016
146 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
147 INTESTINAL ANASTOMOSIS 1 0.0016
148 PAROTID GLAND ENLARGEMENT 1 0.0015
149 APPLICATION SITE PARAESTHESIA 2 0.0015
150 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
151 LIP EXFOLIATION 2 0.0015
152 INJECTION SITE EXFOLIATION 1 0.0015
153 PRODUCT SIZE ISSUE 8 0.0015
154 CRANIAL NERVE DISORDER 1 0.0014
155 FACIAL DISCOMFORT 1 0.0014
156 APPLICATION SITE PAIN 31 0.0014
157 APPLICATION SITE SCAB 3 0.0014
158 DISSOCIATIVE DISORDER 1 0.0014
159 DERMATITIS 29 0.0014
160 GASTROINTESTINAL SCARRING 1 0.0014
161 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
162 WITHDRAWAL BLEED 1 0.0014
163 CONDITION AGGRAVATED 417 0.0014
164 FIBROCYSTIC BREAST DISEASE 1 0.0014
165 MENTAL FATIGUE 2 0.0013
166 SWELLING OF EYELID 8 0.0013
167 THERAPEUTIC RESPONSE DECREASED 77 0.0013
168 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
169 LIP ERYTHEMA 1 0.0013
170 ENDOMETRIAL HYPERPLASIA 1 0.0012
171 KETONURIA 1 0.0012
172 BREAST OPERATION 1 0.0012
173 DERMAL CYST 3 0.0012
174 APPLICATION SITE ERYTHEMA 32 0.0012
175 CSF PROTEIN INCREASED 1 0.0012
176 COVID-19 IMMUNISATION 1 0.0012
177 CARDIAC OUTPUT DECREASED 1 0.0011
178 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
179 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 78 0.0011
180 LYMPH NODE PAIN 2 0.0011
181 TONGUE INJURY 1 0.0011
182 PULPITIS DENTAL 1 0.0011
183 SKIN ABRASION 5 0.0011
184 HEPATIC CONGESTION 1 0.0011
185 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
186 SCAB 12 0.0011
187 RED BLOOD CELL ABNORMALITY 1 0.0010
188 SKIN SWELLING 9 0.0010
189 ATROPHY 2 0.0010
190 BLOOD IRON ABNORMAL 1 0.0010
191 SKIN FISSURES 20 0.0010
192 APPLICATION SITE SWELLING 5 0.0010
193 SKIN PAPILLOMA 4 0.0010
194 DERMATITIS ACNEIFORM 6 0.0010
195 APPLICATION SITE DISCOLOURATION 4 0.0010
196 EYELID PAIN 2 0.0010
197 DERMATITIS PSORIASIFORM 2 0.0010
198 BONE MARROW OEDEMA 1 0.0010
199 EYELIDS PRURITUS 3 0.0010
200 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
201 THYROID HORMONES INCREASED 1 0.0010
202 SINUSITIS BACTERIAL 1 0.0009
203 APPLICATION SITE PAPULES 1 0.0009
204 SUNBURN 7 0.0009
205 TINEA INFECTION 1 0.0009
206 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
207 PERIRECTAL ABSCESS 1 0.0009
208 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
209 HYPERSENSITIVITY 166 0.0009
210 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
211 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
212 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
213 PHOBIA 1 0.0009
214 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
215 MACROCYTOSIS 1 0.0009
216 OSTEOCHONDROSIS 1 0.0009
217 ROSACEA 4 0.0009
218 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
219 INTRUSIVE THOUGHTS 1 0.0008
220 EYELID SKIN DRYNESS 1 0.0008
221 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
222 RASH MACULAR 28 0.0008
223 APPLICATION SITE RASH 11 0.0008
224 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
225 RASH 347 0.0008
226 ENDOCRINE DISORDER 1 0.0008
227 ABDOMINAL OPERATION 1 0.0008
228 WHITE BLOOD CELL DISORDER 2 0.0007
229 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
230 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
231 SKIN WRINKLING 2 0.0007
232 SIALOADENITIS 1 0.0007
233 SKIN DEPIGMENTATION 1 0.0007
234 CORNEAL ABRASION 1 0.0007
235 RASH MACULO-PAPULAR 16 0.0007
236 INTRACRANIAL PRESSURE INCREASED 4 0.0007
237 JOINT INSTABILITY 1 0.0007
238 PERIODONTAL DISEASE 1 0.0007
239 MAST CELL ACTIVATION SYNDROME 1 0.0007
240 APPLICATION SITE PRURITUS 16 0.0007
241 AUDITORY DISORDER 1 0.0007
242 HAEMORRHAGE IN PREGNANCY 1 0.0007
243 NAIL INFECTION 1 0.0007
244 SKIN ATROPHY 4 0.0007
245 PRODUCT MONITORING ERROR 1 0.0007
246 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
247 SEBORRHOEIC KERATOSIS 1 0.0007
248 GENERALISED ANXIETY DISORDER 1 0.0007
249 ADVERSE REACTION 9 0.0007
250 SWELLING FACE 44 0.0007
251 PAPILLOEDEMA 3 0.0007
252 MEAN CELL VOLUME DECREASED 1 0.0006
253 NEURITIS 1 0.0006
254 OSTEOMALACIA 1 0.0006
255 POLYCYSTIC OVARIES 1 0.0006
256 NEOPLASM SKIN 1 0.0006
257 ENTHESOPATHY 1 0.0006
258 BLOOD CREATININE DECREASED 2 0.0006
259 SCLERITIS 1 0.0006
260 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
261 SKIN HAEMORRHAGE 9 0.0006
262 SEBORRHOEIC DERMATITIS 1 0.0006
263 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
264 MEDICAL PROCEDURE 1 0.0006
265 ANXIETY DISORDER 2 0.0006
266 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
267 BILIARY DYSKINESIA 1 0.0006
268 SKIN WOUND 1 0.0006
269 RASH ERYTHEMATOUS 28 0.0006
270 MILIARIA 1 0.0006
271 LEFT VENTRICULAR FAILURE 2 0.0006
272 FOLLICULITIS 6 0.0006
273 ROTATOR CUFF REPAIR 1 0.0006
274 INFUSION SITE DISCHARGE 1 0.0006
275 KYPHOSIS 1 0.0006
276 SKIN HYPOPIGMENTATION 1 0.0006
277 MITRAL VALVE DISEASE 1 0.0006
278 ILEAL STENOSIS 1 0.0006
279 ANAL FISTULA 3 0.0006
280 SKIN WEEPING 2 0.0006
281 APPLICATION SITE DISCOMFORT 1 0.0006
282 DERMATITIS ALLERGIC 7 0.0006
283 OPHTHALMIC HERPES ZOSTER 1 0.0006
284 NASAL OEDEMA 1 0.0006
285 DEVICE ALARM ISSUE 1 0.0006
286 BLOOD PHOSPHORUS DECREASED 2 0.0005
287 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
288 ESSENTIAL HYPERTENSION 1 0.0005
289 SKIN DISCOLOURATION 25 0.0005
290 EYE SWELLING 20 0.0005
291 NEURODERMATITIS 2 0.0005
292 BLOOD CHOLESTEROL DECREASED 1 0.0005
293 BLADDER SPASM 1 0.0005
294 HEPATIC MASS 1 0.0005
295 PANIC DISORDER 2 0.0005
296 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
297 BURNING SENSATION 36 0.0005
298 JOINT NOISE 1 0.0005
299 MULTI-ORGAN DISORDER 1 0.0005
300 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
301 OESOPHAGEAL PAIN 2 0.0005
302 JOINT CREPITATION 1 0.0005
303 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
304 REBOUND ATOPIC DERMATITIS 1 0.0005
305 CHANGE OF BOWEL HABIT 1 0.0005
306 HYPERPARATHYROIDISM 1 0.0005
307 MICROCYTIC ANAEMIA 1 0.0005
308 POST PROCEDURAL DISCOMFORT 1 0.0005
309 SHOULDER OPERATION 2 0.0005
310 PRODUCT CONTAINER ISSUE 4 0.0005
311 EXOPHTHALMOS 1 0.0005
312 SPUTUM INCREASED 1 0.0005
313 HORDEOLUM 2 0.0005
314 OSTEOPENIA 7 0.0005
315 CHAPPED LIPS 2 0.0005
316 GASTRIC BYPASS 1 0.0005
317 COLONOSCOPY 1 0.0005
318 MIDDLE EAR EFFUSION 1 0.0005
319 FAECES PALE 1 0.0004
320 INFECTIOUS MONONUCLEOSIS 1 0.0004
321 EYELID DISORDER 1 0.0004
322 REACTION TO EXCIPIENT 1 0.0004
323 PATELLA FRACTURE 1 0.0004
324 APPLICATION SITE REACTION 3 0.0004
325 PHOTOSENSITIVITY REACTION 7 0.0004
326 VOLVULUS 1 0.0004
327 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
328 PRODUCT PACKAGING ISSUE 4 0.0004
329 OXYGEN CONSUMPTION INCREASED 1 0.0004
330 GASTROINTESTINAL OBSTRUCTION 1 0.0004
331 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
332 RASH PUSTULAR 3 0.0004
333 SKIN FRAGILITY 1 0.0004
334 BREATH ODOUR 1 0.0004
335 INCORRECT DOSAGE ADMINISTERED 2 0.0004
336 RETINAL TEAR 1 0.0004
337 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
338 DEVICE INFUSION ISSUE 1 0.0004
339 HYPERPARATHYROIDISM SECONDARY 1 0.0004
340 OSTEITIS 1 0.0004
341 EXCORIATION 1 0.0004
342 ILEOSTOMY 1 0.0004
343 ABNORMAL UTERINE BLEEDING 1 0.0004
344 HEPATOSPLENOMEGALY 1 0.0004
345 MEDICATION RESIDUE 1 0.0004
346 LIPOMA 1 0.0004
347 ACTINIC KERATOSIS 1 0.0004
348 PRURITUS 146 0.0004
349 PNEUMOTHORAX 6 0.0004
350 BLOOD ALBUMIN DECREASED 3 0.0004
351 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
352 ALCOHOL ABUSE 1 0.0004
353 STEATORRHOEA 1 0.0004
354 COMPRESSION FRACTURE 2 0.0004
355 URINARY INCONTINENCE 11 0.0004
356 ERYTHEMA OF EYELID 2 0.0004
357 INFLAMMATION 19 0.0004
358 MIGRAINE WITH AURA 1 0.0004
359 SKIN LACERATION 4 0.0004
360 PALLOR 10 0.0004
361 APPLICATION SITE HAEMORRHAGE 1 0.0004
362 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
363 MACULE 1 0.0004
364 NEUTROPHILIA 2 0.0004
365 VITAMIN D DECREASED 3 0.0004
366 DERMATITIS CONTACT 4 0.0004
367 PNEUMATOSIS INTESTINALIS 1 0.0004
368 LIP PAIN 1 0.0003
369 BLOOD MAGNESIUM DECREASED 3 0.0003
370 FIBULA FRACTURE 1 0.0003
371 PARAESTHESIA ORAL 5 0.0003
372 MOUTH SWELLING 2 0.0003
373 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
374 HAEMOTHORAX 1 0.0003
375 STRABISMUS 1 0.0003
376 TOOTH DISCOLOURATION 1 0.0003
377 BONE MARROW DISORDER 1 0.0003
378 REBOUND ACID HYPERSECRETION 1 0.0003
379 PRODUCT SUBSTITUTION ISSUE 19 0.0003
380 DUODENITIS 1 0.0003
381 BLOOD BLISTER 1 0.0003
382 NASAL DRYNESS 2 0.0003
383 ABORTION INDUCED 3 0.0003
384 RESPIRATORY RATE DECREASED 1 0.0003
385 INFUSION SITE PRURITUS 1 0.0003
386 THERAPEUTIC RESPONSE CHANGED 2 0.0003
387 HEPATITIS ACUTE 2 0.0003
388 FACET JOINT SYNDROME 1 0.0003
389 PHARYNGEAL SWELLING 3 0.0003
390 HEPATIC NEOPLASM 1 0.0003
391 ANHEDONIA 8 0.0003
392 LIP SWELLING 10 0.0003
393 WRONG PRODUCT ADMINISTERED 2 0.0003
394 ULCER HAEMORRHAGE 2 0.0003
395 OCULAR HYPERAEMIA 14 0.0003
396 DYSARTHRIA 11 0.0003
397 CROHN'S DISEASE 2 0.0003
398 SKIN LESION 8 0.0003
399 JOINT EFFUSION 2 0.0003
400 EXPOSURE DURING PREGNANCY 18 0.0003
401 PRODUCT ODOUR ABNORMAL 3 0.0003
402 HANGOVER 1 0.0003
403 PAPULE 2 0.0003
404 JAUNDICE CHOLESTATIC 1 0.0003
405 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
406 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
407 DEVICE PLACEMENT ISSUE 1 0.0003
408 IMPAIRED QUALITY OF LIFE 4 0.0003
409 BIPOLAR DISORDER 3 0.0003
410 PARADOXICAL DRUG REACTION 1 0.0003
411 STEVENS-JOHNSON SYNDROME 6 0.0003
412 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
413 ECZEMA 14 0.0003
414 SKIN INFECTION 3 0.0003
415 DERMATITIS ATOPIC 14 0.0003
416 SNORING 1 0.0003
417 FACE INJURY 1 0.0003
418 DISCOMFORT 16 0.0003
419 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
420 LIPASE INCREASED 2 0.0003
421 NEOPLASM 3 0.0003
422 EYE IRRITATION 15 0.0003
423 ACUTE RESPIRATORY FAILURE 5 0.0003
424 OESOPHAGEAL DISORDER 1 0.0003
425 FOOD ALLERGY 2 0.0003
426 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
427 THERAPY PARTIAL RESPONDER 4 0.0003
428 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
429 SKIN ODOUR ABNORMAL 1 0.0003
430 RENAL CYST 2 0.0003
431 EXPOSURE VIA BREAST MILK 1 0.0003
432 BLISTER 14 0.0002
433 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
434 FUNGAL SKIN INFECTION 1 0.0002
435 PRODUCT ADMINISTRATION ERROR 5 0.0002
436 BURSITIS 3 0.0002
437 SWELLING 23 0.0002
438 TRIGGER FINGER 1 0.0002
439 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
440 EXPIRED PRODUCT ADMINISTERED 8 0.0002
441 CONGESTIVE CARDIOMYOPATHY 1 0.0002
442 SKIN DISORDER 8 0.0002
443 URTICARIA 40 0.0002
444 HALLUCINATIONS, MIXED 1 0.0002
445 TREATMENT NONCOMPLIANCE 13 0.0002
446 BUNDLE BRANCH BLOCK LEFT 1 0.0002
447 UTERINE HAEMORRHAGE 1 0.0002
448 INTERVERTEBRAL DISC DISORDER 1 0.0002
449 PURULENT DISCHARGE 1 0.0002
450 PRODUCT DISPENSING ISSUE 1 0.0002
451 ONYCHOMYCOSIS 1 0.0002
452 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
453 PHYSICAL DISABILITY 1 0.0002
454 WRONG DRUG ADMINISTERED 2 0.0002
455 THERAPY NON-RESPONDER 10 0.0002
456 VASCULAR DEVICE INFECTION 1 0.0002
457 LIP DRY 2 0.0002
458 URINE ABNORMALITY 1 0.0002
459 HIDRADENITIS 2 0.0002
460 ABDOMINAL HERNIA 1 0.0002
461 PERIPHERAL COLDNESS 3 0.0002
462 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
463 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
464 EYE OPERATION 1 0.0002
465 UROSEPSIS 2 0.0002
466 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
467 ERYTHEMA MULTIFORME 2 0.0002
468 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
469 TIBIA FRACTURE 1 0.0002
470 EYE PAIN 12 0.0002
471 VAGINAL INFECTION 1 0.0002
472 ENDOMETRIOSIS 1 0.0002
473 SLEEP APNOEA SYNDROME 4 0.0002
474 SUBCUTANEOUS ABSCESS 1 0.0002
475 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
476 FAECAL INCONTINENCE 1 0.0002
477 GUILLAIN-BARRE SYNDROME 1 0.0002
478 MENTAL IMPAIRMENT 5 0.0002
479 MUCOUS STOOLS 1 0.0002
480 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
481 VEIN DISORDER 1 0.0002
482 VULVOVAGINAL PRURITUS 1 0.0002
483 DRUG DISPENSING ERROR 3 0.0002
484 SLUGGISHNESS 2 0.0002
485 AMMONIA INCREASED 1 0.0002
486 NEUTROPHIL COUNT INCREASED 2 0.0002
487 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
488 CACHEXIA 1 0.0002
489 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
490 FAILURE TO THRIVE 1 0.0002
491 BRAIN FOG 3 0.0002
492 PHARYNGOLARYNGEAL PAIN 1 0.0002
493 INJECTION SITE DISCHARGE 1 0.0002
494 PRODUCT RESIDUE PRESENT 1 0.0002
495 BEHAVIOUR DISORDER 1 0.0002
496 MOOD ALTERED 5 0.0002
497 OESOPHAGITIS 2 0.0002
498 MULTIPLE FRACTURES 3 0.0002
499 FAECALOMA 1 0.0002
500 NONSPECIFIC REACTION 1 0.0002
501 FOOT DEFORMITY 2 0.0002
502 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
503 MALNUTRITION 2 0.0002
504 EYE PRURITUS 6 0.0002
505 ACUTE PULMONARY OEDEMA 1 0.0002
506 PARAESTHESIA 28 0.0002
507 HYPONATRAEMIA 10 0.0002
508 COLECTOMY 1 0.0002
509 INTERNAL HAEMORRHAGE 2 0.0002
510 EXERCISE TOLERANCE DECREASED 1 0.0002
511 METABOLIC DISORDER 1 0.0002
512 ELECTROLYTE IMBALANCE 2 0.0002
513 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
514 HYPOVOLAEMIA 1 0.0002
515 HYPERTRIGLYCERIDAEMIA 1 0.0002
516 OSTEOPOROSIS 7 0.0002
517 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
518 TREATMENT FAILURE 14 0.0002
519 DISEASE RECURRENCE 8 0.0002
520 ODYNOPHAGIA 1 0.0002
521 ADVERSE DRUG REACTION 15 0.0002
522 GASTROENTERITIS VIRAL 3 0.0002
523 INJECTION SITE VESICLES 1 0.0002
524 VULVOVAGINAL BURNING SENSATION 1 0.0002
525 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
526 SCOLIOSIS 1 0.0002
527 INFUSION SITE EXTRAVASATION 1 0.0002
528 PRE-EXISTING CONDITION IMPROVED 1 0.0002
529 INFUSION SITE SWELLING 1 0.0002
530 MULTIPLE INJURIES 1 0.0002
531 MIGRAINE 15 0.0002
532 HAEMOGLOBIN ABNORMAL 1 0.0002
533 INFUSION SITE PAIN 2 0.0002
534 APPLICATION SITE VESICLES 1 0.0002
535 AMNESIA 10 0.0002
536 MUCOSAL INFLAMMATION 4 0.0002
537 BEDRIDDEN 2 0.0002
538 WALKING AID USER 1 0.0002
539 PRODUCT FORMULATION ISSUE 1 0.0002
540 SINUS DISORDER 3 0.0002
541 HAEMATOCRIT DECREASED 3 0.0002
542 SKIN MASS 1 0.0001
543 SPINAL FRACTURE 3 0.0001
544 CHOLECYSTITIS CHRONIC 1 0.0001
545 PRODUCT USE ISSUE 28 0.0001
546 POSTOPERATIVE WOUND INFECTION 1 0.0001
547 RASH PRURITIC 8 0.0001
548 IMPAIRED GASTRIC EMPTYING 2 0.0001
549 ONYCHOCLASIS 1 0.0001
550 HAIR GROWTH ABNORMAL 1 0.0001
551 APHONIA 2 0.0001
552 PULMONARY TOXICITY 1 0.0001
553 SEASONAL ALLERGY 2 0.0001
554 THERMAL BURN 1 0.0001
555 NEUTROPENIC SEPSIS 1 0.0001
556 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
557 TONGUE DISORDER 1 0.0001
558 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
559 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
560 INTENTIONAL UNDERDOSE 1 0.0001
561 ORAL DISORDER 1 0.0001
562 HYPOPHOSPHATAEMIA 1 0.0001
563 FEELING DRUNK 1 0.0001
564 IMMUNODEFICIENCY 2 0.0001
565 ECONOMIC PROBLEM 2 0.0001
566 HEPATOCELLULAR CARCINOMA 1 0.0001
567 HAEMODYNAMIC INSTABILITY 1 0.0001
568 HYPERTHERMIA 1 0.0001
569 INSURANCE ISSUE 2 0.0001
570 MUSCLE TWITCHING 3 0.0001
571 RENAL FAILURE CHRONIC 1 0.0001
572 ATRIOVENTRICULAR BLOCK 1 0.0001
573 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
574 BONE DENSITY DECREASED 4 0.0001
575 MULTIPLE ALLERGIES 1 0.0001
576 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
577 AFFECTIVE DISORDER 1 0.0001
578 PRODUCT USE COMPLAINT 2 0.0001
579 DRUG SCREEN POSITIVE 1 0.0001
580 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
581 FURUNCLE 1 0.0001
582 NEURALGIA 3 0.0001
583 PSORIASIS 16 0.0001
584 HYPERAESTHESIA 1 0.0001
585 BLOOD UREA INCREASED 2 0.0001
586 ATRIAL SEPTAL DEFECT 1 0.0001
587 SURGERY 7 0.0001
588 SENSATION OF FOREIGN BODY 1 0.0001
589 INFUSION SITE ERYTHEMA 1 0.0001
590 SKIN PLAQUE 1 0.0001
591 DYSPHAGIA 11 0.0001
592 CARDIAC MURMUR 1 0.0001
593 AMENORRHOEA 2 0.0001
594 GROIN PAIN 1 0.0001
595 SPINAL OSTEOARTHRITIS 1 0.0001
596 DRUG ERUPTION 2 0.0001
597 EAR INFECTION 3 0.0001
598 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
599 GASTROINTESTINAL DISORDER 10 0.0001
600 LEUKOCYTOSIS 2 0.0001
601 PANIC ATTACK 4 0.0001
602 RETINAL DETACHMENT 1 0.0001
603 DYSURIA 4 0.0001
604 NERVE COMPRESSION 1 0.0001
605 PERSONALITY CHANGE 1 0.0001
606 WOUND 3 0.0001
607 MIDDLE INSOMNIA 2 0.0001
608 SQUAMOUS CELL CARCINOMA 1 0.0001
609 BLOOD URINE PRESENT 2 0.0001
610 GASTRIC ULCER 2 0.0001
611 FEELING JITTERY 2 0.0001
612 EYE INFLAMMATION 1 0.0001
613 AFFECT LABILITY 1 0.0001
614 ATELECTASIS 1 0.0001
615 SINUS BRADYCARDIA 1 0.0001
616 DIZZINESS POSTURAL 1 0.0001
617 VITAMIN D DEFICIENCY 1 0.0001
618 HAEMORRHOIDS 2 0.0001
619 COELIAC DISEASE 1 0.0001
620 VITREOUS FLOATERS 1 0.0001
621 LIGAMENT SPRAIN 1 0.0001
622 DEPRESSION 23 0.0001
623 PAIN 62 0.0001
624 INABILITY TO AFFORD MEDICATION 1 0.0001
625 OVARIAN CYST 1 0.0001
626 SALIVARY HYPERSECRETION 1 0.0001
627 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
628 INJURY 7 0.0001
629 APHASIA 3 0.0001
630 PRODUCT PHYSICAL ISSUE 2 0.0001
631 INTENTIONAL SELF-INJURY 2 0.0001
632 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
633 DRY THROAT 1 0.0001
634 DRUG LEVEL DECREASED 1 0.0001
635 PRODUCT PREPARATION ERROR 2 0.0001
636 RIB FRACTURE 2 0.0001
637 TEMPERATURE INTOLERANCE 1 0.0001
638 VENTRICULAR EXTRASYSTOLES 1 0.0001
639 TENDERNESS 1 0.0001
640 RHABDOMYOLYSIS 4 0.0001
641 SCRATCH 1 0.0001
642 JOINT DISLOCATION 1 0.0001
643 CONTUSION 9 0.0001
644 IRRITABLE BOWEL SYNDROME 2 0.0001
645 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
646 CHRONIC KIDNEY DISEASE 7 0.0001
647 BACK INJURY 1 0.0001
648 PRODUCT DISPENSING ERROR 2 0.0001
649 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
650 CHOLELITHIASIS 3 0.0001
651 INTENTIONAL PRODUCT MISUSE 8 0.0001
652 INJECTION SITE SWELLING 7 0.0001
653 EYE DISORDER 3 0.0001
654 INJECTION SITE NODULE 1 0.0001
655 ANAPHYLACTIC REACTION 5 0.0001
656 DENTAL CARIES 1 0.0001
657 RASH PAPULAR 2 0.0001
658 BLOOD CALCIUM DECREASED 1 0.0001
659 CHROMATURIA 2 0.0001
660 EYE INFECTION 1 0.0001
661 HEART RATE IRREGULAR 2 0.0001
662 REBOUND EFFECT 1 0.0001
663 PRODUCT QUALITY ISSUE 12 0.0001
664 IMPAIRED DRIVING ABILITY 1 0.0001
665 CHOLECYSTECTOMY 1 0.0001
666 LETHARGY 5 0.0001
667 EYELID OEDEMA 1 0.0001
668 SEXUAL DYSFUNCTION 1 0.0001
669 SLEEP DISORDER 6 0.0001
670 COVID-19 PNEUMONIA 1 0.0001
671 BLOOD IRON DECREASED 1 0.0001
672 CHOLECYSTITIS 1 0.0001
673 WRIST FRACTURE 1 0.0001
674 BLOOD PRESSURE FLUCTUATION 2 0.0001
675 HEPATITIS C 1 0.0001
676 EMOTIONAL DISTRESS 10 0.0001
677 SCHIZOPHRENIA 1 0.0001
678 PRESYNCOPE 2 0.0001
679 PLEURAL EFFUSION 5 0.0001
680 LUNG DISORDER 4 0.0001
681 INJECTION SITE URTICARIA 2 0.0001
682 OSTEONECROSIS OF JAW 2 0.0001
683 PHARYNGITIS 1 0.0001
684 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
685 DRY EYE 4 0.0001
686 INJECTION SITE DISCOLOURATION 1 0.0001
687 ASTHMA 9 0.0001
688 POISONING 1 0.0001
689 PRODUCT COMPLAINT 2 0.0001
690 HAEMATEMESIS 2 0.0001
691 HEPATITIS 2 0.0001
692 CHEST DISCOMFORT 8 0.0001
693 ABDOMINAL PAIN 18 0.0001
694 INCORRECT PRODUCT STORAGE 1 0.0001
695 ADVERSE EVENT 7 0.0001
696 ORAL CANDIDIASIS 1 0.0001
697 IMMUNE SYSTEM DISORDER 1 0.0001
698 TOOTH INFECTION 1 0.0001
699 SARS-COV-2 TEST POSITIVE 1 0.0001
700 DYSMENORRHOEA 1 0.0001
701 HAIR TEXTURE ABNORMAL 1 0.0001
702 JAUNDICE 2 0.0001
703 BLOOD BILIRUBIN INCREASED 2 0.0001
704 SINUS CONGESTION 1 0.0001
705 PSORIATIC ARTHROPATHY 3 0.0001
706 INJECTION SITE REACTION 5 0.0001
707 ORAL DISCOMFORT 1 0.0001
708 HAEMOPTYSIS 2 0.0001
709 NECK PAIN 4 0.0001
710 WEIGHT INCREASED 16 0.0001
711 LYMPHOPENIA 1 0.0001
712 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
713 SINUS TACHYCARDIA 1 0.0001
714 INTENTIONAL DOSE OMISSION 2 0.0001
715 HYPERSOMNIA 2 0.0001
716 HERPES ZOSTER 4 0.0001
717 HYPERTHYROIDISM 1 0.0001
718 MENTAL DISORDER 3 0.0001
719 HYPOKINESIA 1 0.0001
720 LIVER FUNCTION TEST ABNORMAL 2 0.0001
721 GASTROENTERITIS 1 0.0001
722 NASAL CONGESTION 4 0.0001
723 RENAL INJURY 2 0.0001
724 ANXIETY 19 0.0001
725 HYPOAESTHESIA ORAL 1 0.0001
726 UNEVALUABLE EVENT 5 0.0001
727 INJECTION SITE RASH 2 0.0001
728 DEVICE RELATED INFECTION 1 0.0001
729 THYROID DISORDER 1 0.0001
730 ANKLE FRACTURE 1 0.0001
731 TENDONITIS 1 0.0001
732 BASAL CELL CARCINOMA 1 0.0001
733 CYANOSIS 1 0.0001
734 ULCER 1 0.0001
735 SCIATICA 1 0.0001
736 SENSORY DISTURBANCE 1 0.0001
737 INFECTION 9 0.0001
738 HYPERHIDROSIS 8 0.0001
739 PRODUCT DOSE OMISSION 4 0.0001
740 STAPHYLOCOCCAL INFECTION 2 0.0001
741 VIRAL INFECTION 2 0.0001
742 FUNGAL INFECTION 2 0.0001
743 FACE OEDEMA 1 0.0001
744 CANDIDA INFECTION 1 0.0001
745 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
746 DIZZINESS 29 0.0001
747 VOMITING 27 0.0001
748 NEUROTOXICITY 1 0.0001
749 LYMPHOCYTE COUNT DECREASED 1 0.0001
750 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
751 GOUT 1 0.0001
752 COMPLICATION OF DEVICE REMOVAL 1 0.0001
753 TOOTHACHE 1 0.0001
754 DRUG EFFECT INCOMPLETE 2 0.0001
755 PELVIC PAIN 1 0.0001
756 CRYING 2 0.0001
757 BONE DISORDER 1 0.0001
758 END STAGE RENAL DISEASE 1 0.0001
759 LOSS OF CONSCIOUSNESS 7 0.0001
760 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
761 AGITATION 4 0.0001
762 PRODUCT DOSE OMISSION ISSUE 16 0.0001
763 FEELING ABNORMAL 13 0.0001
764 INFLUENZA 6 0.0001
765 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
766 HEPATIC CIRRHOSIS 1 0.0001
767 PHOTOPHOBIA 1 0.0001
768 FOOT FRACTURE 1 0.0001
769 PULMONARY EMBOLISM 5 0.0001
770 INCREASED APPETITE 1 0.0001
771 SEROTONIN SYNDROME 1 0.0001
772 DRUG PRESCRIBING ERROR 1 0.0001
773 SEIZURE 6 0.0001
774 CHOKING 1 0.0001
775 DISABILITY 1 0.0001
776 HEART RATE INCREASED 5 0.0001
777 BLOOD PRESSURE ABNORMAL 1 0.0001
778 COMPLICATION OF DEVICE INSERTION 1 0.0001
779 OFF LABEL USE 44 0.0001
780 JOINT SWELLING 6 0.0000
781 FULL BLOOD COUNT DECREASED 1 0.0000
782 TASTE DISORDER 1 0.0000
783 DEVICE BREAKAGE 2 0.0000
784 BONE MARROW FAILURE 1 0.0000
785 INJURY ASSOCIATED WITH DEVICE 1 0.0000
786 CHEST PAIN 9 0.0000
787 TOOTH LOSS 1 0.0000
788 PULMONARY HYPERTENSION 1 0.0000
789 HAEMORRHAGE 5 0.0000
790 WITHDRAWAL SYNDROME 2 0.0000
791 EATING DISORDER 1 0.0000
792 POOR QUALITY SLEEP 1 0.0000
793 PRURITUS GENERALISED 1 0.0000
794 FAECES DISCOLOURED 1 0.0000
795 BLOOD CREATININE INCREASED 3 0.0000
796 NAUSEA 36 0.0000
797 PERIPHERAL SWELLING 7 0.0000
798 ANGIOEDEMA 2 0.0000
799 TACHYCARDIA 4 0.0000
800 TRANSAMINASES INCREASED 1 0.0000
801 INJECTION SITE PRURITUS 3 0.0000
802 GLOSSODYNIA 1 0.0000
803 HEADACHE 28 0.0000
804 HEPATIC ENZYME INCREASED 3 0.0000
805 MUSCULAR WEAKNESS 5 0.0000
806 SUICIDAL IDEATION 4 0.0000
807 MEMORY IMPAIRMENT 6 0.0000
808 NEPHROLITHIASIS 2 0.0000
809 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
810 PERICARDIAL EFFUSION 1 0.0000
811 OROPHARYNGEAL PAIN 4 0.0000
812 COGNITIVE DISORDER 2 0.0000
813 PALPITATIONS 5 0.0000
814 THERAPY INTERRUPTED 3 0.0000
815 MULTIPLE SCLEROSIS 2 0.0000
816 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
817 HEPATIC CANCER 1 0.0000
818 LOCALISED INFECTION 1 0.0000
819 ALOPECIA 8 0.0000
820 BRONCHITIS 3 0.0000
821 AGEUSIA 1 0.0000
822 HYPOAESTHESIA 6 0.0000
823 CELLULITIS 2 0.0000
824 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
825 WEIGHT DECREASED 11 0.0000
826 FLUSHING 4 0.0000
827 BLOOD PRESSURE INCREASED 6 0.0000
828 SINUSITIS 4 0.0000
829 ERECTILE DYSFUNCTION 1 0.0000
830 ILLNESS 4 0.0000
831 ANAPHYLACTIC SHOCK 1 0.0000
832 SKIN ULCER 1 0.0000
833 HAEMATOMA 1 0.0000
834 EXPOSURE VIA SKIN CONTACT 1 0.0000
835 DIPLOPIA 1 0.0000
836 ABDOMINAL DISTENSION 4 0.0000
837 DEAFNESS 1 0.0000
838 SEDATION 1 0.0000
839 SPEECH DISORDER 2 0.0000
840 MUSCLE SPASMS 7 0.0000
841 GASTRITIS 1 0.0000
842 PANCREATITIS 2 0.0000
843 HYPERTENSION 8 0.0000
844 INJECTION SITE HAEMORRHAGE 3 0.0000
845 PLATELET COUNT DECREASED 4 0.0000
846 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
847 FATIGUE 29 0.0000
848 BLOOD GLUCOSE INCREASED 7 0.0000
849 DRUG EFFECT DECREASED 2 0.0000
850 DISTURBANCE IN ATTENTION 2 0.0000
851 FREQUENT BOWEL MOVEMENTS 1 0.0000
852 OEDEMA 2 0.0000
853 NEUTROPENIA 5 0.0000
854 HAEMATOCHEZIA 2 0.0000
855 DIVERTICULITIS 1 0.0000
856 FALL 12 0.0000
857 MENTAL STATUS CHANGES 1 0.0000
858 ARTHROPATHY 2 0.0000
859 RENAL IMPAIRMENT 3 0.0000
860 RED BLOOD CELL COUNT DECREASED 1 0.0000
861 PYREXIA 12 0.0000
862 NEEDLE ISSUE 1 0.0000
863 MUSCULOSKELETAL STIFFNESS 3 0.0000
864 MALAISE 15 0.0000
865 ASCITES 1 0.0000
866 IRRITABILITY 2 0.0000
867 HEPATIC FAILURE 1 0.0000
868 LACRIMATION INCREASED 1 0.0000
869 ILL-DEFINED DISORDER 2 0.0000
870 VERTIGO 2 0.0000
871 INJECTION SITE PAIN 10 0.0000
872 EMOTIONAL DISORDER 1 0.0000
873 SWOLLEN TONGUE 1 0.0000
874 DRUG-INDUCED LIVER INJURY 1 0.0000
875 DYSPNOEA 18 0.0000
876 HEAD INJURY 1 0.0000
877 DRUG INTERACTION 5 0.0000
878 MOOD SWINGS 1 0.0000
879 GAIT DISTURBANCE 6 0.0000
880 ARTHRALGIA 13 0.0000
881 MOVEMENT DISORDER 1 0.0000
882 DRUG INTOLERANCE 3 0.0000
883 NIGHT SWEATS 1 0.0000
884 RHINORRHOEA 2 0.0000
885 DEVICE EXPULSION 2 0.0000
886 BACK PAIN 7 0.0000
887 BLOOD PRESSURE DECREASED 2 0.0000
888 INSOMNIA 8 0.0000
889 SYNCOPE 3 0.0000
890 URINARY RETENTION 1 0.0000
891 SOMNOLENCE 6 0.0000
892 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
893 MYALGIA 5 0.0000
894 HAEMOGLOBIN DECREASED 3 0.0000
895 HAEMATURIA 1 0.0000
896 VISION BLURRED 4 0.0000
897 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
898 DELIRIUM 1 0.0000
899 HYPOXIA 1 0.0000
900 LYMPHADENOPATHY 1 0.0000
901 CONSTIPATION 6 0.0000
902 C-REACTIVE PROTEIN INCREASED 1 0.0000
903 NASOPHARYNGITIS 5 0.0000
904 INJECTION SITE MASS 1 0.0000
905 ASTHENIA 10 0.0000
906 COLITIS 1 0.0000
907 INCORRECT DOSE ADMINISTERED 6 0.0000
908 DIABETES MELLITUS 2 0.0000
909 ACUTE KIDNEY INJURY 4 0.0000
910 HOSPITALISATION 4 0.0000
911 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
912 PLASMA CELL MYELOMA 1 0.0000
913 DISEASE PROGRESSION 3 0.0000
914 INJECTION SITE BRUISING 2 0.0000
915 ABORTION SPONTANEOUS 1 0.0000
916 THROMBOSIS 2 0.0000
917 CONFUSIONAL STATE 4 0.0000
918 EXTRA DOSE ADMINISTERED 1 0.0000
919 NEUTROPHIL COUNT DECREASED 1 0.0000
920 ABDOMINAL PAIN UPPER 5 0.0000
921 VISUAL IMPAIRMENT 3 0.0000
922 TREMOR 4 0.0000
923 COMPLETED SUICIDE 2 0.0000
924 POLLAKIURIA 1 0.0000
925 ABDOMINAL DISCOMFORT 4 0.0000
926 PAIN IN EXTREMITY 7 0.0000
927 URINARY TRACT INFECTION 4 0.0000
928 DRUG WITHDRAWAL SYNDROME 2 0.0000
929 RENAL FAILURE 3 0.0000
930 LIVER DISORDER 1 0.0000
931 DEHYDRATION 3 0.0000
932 COLITIS ULCERATIVE 1 0.0000
933 PULMONARY OEDEMA 1 0.0000
934 THROAT IRRITATION 1 0.0000
935 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
936 TINNITUS 1 0.0000
937 DECREASED APPETITE 5 0.0000
938 RENAL DISORDER 1 0.0000
939 BLOOD CHOLESTEROL INCREASED 1 0.0000
940 COUGH 6 0.0000
941 ARRHYTHMIA 1 0.0000
942 NEUROPATHY PERIPHERAL 2 0.0000
943 COMA 1 0.0000
944 RENAL CANCER 1 0.0000
945 PRODUCTIVE COUGH 1 0.0000
946 HYPOGLYCAEMIA 1 0.0000
947 DYSPEPSIA 2 0.0000
948 AGGRESSION 1 0.0000
949 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
950 BRADYCARDIA 1 0.0000
951 DIARRHOEA 12 0.0000
952 PNEUMONIA 6 0.0000
953 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
954 MEDICATION ERROR 1 0.0000
955 FLATULENCE 1 0.0000
956 COVID-19 3 0.0000
957 DYSPHONIA 1 0.0000
958 BONE PAIN 1 0.0000
959 WHEEZING 1 0.0000
960 CATARACT 1 0.0000
961 NO ADVERSE EVENT 3 0.0000
962 SUICIDE ATTEMPT 1 0.0000
963 STOMATITIS 1 0.0000
964 FEELING HOT 1 0.0000
965 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
966 INJECTION SITE ERYTHEMA 2 0.0000
967 NEOPLASM MALIGNANT 1 0.0000
968 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
969 DEVICE MALFUNCTION 1 0.0000
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
971 MOBILITY DECREASED 1 0.0000
972 OVERDOSE 3 0.0000
973 RESPIRATORY FAILURE 1 0.0000
974 HOT FLUSH 1 0.0000
975 ARTHRITIS 1 0.0000
976 CARDIAC FAILURE 1 0.0000
977 CARDIAC FAILURE CONGESTIVE 1 0.0000
978 DRUG DOSE OMISSION 2 0.0000
979 CEREBROVASCULAR ACCIDENT 2 0.0000
980 BALANCE DISORDER 1 0.0000
981 PRODUCT STORAGE ERROR 1 0.0000
982 DEVICE ISSUE 1 0.0000
983 BREAST CANCER 1 0.0000
984 ANAEMIA 2 0.0000
985 ATRIAL FIBRILLATION 1 0.0000
986 HYPOTENSION 2 0.0000
987 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
988 OEDEMA PERIPHERAL 1 0.0000
989 DEATH 3 0.0000